Future treatment for asthma.

Abstract excerpt

The landscape of asthma has considerably changed after 40 years of inhaled corticosteroid development and nearly 20 years since the first monoclonal antibodies (mAbs) were approved. New members of pharmacological families and more effective drug-delivery devices have been designed but the proportion of uncontrolled patients, unfortunately, remains stable. The most promising treatments now rely on targeted...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Asthmatic Agents
• Share to Asthma